BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17482433)

  • 1. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes.
    Gaster M
    Biochim Biophys Acta; 2007 Jul; 1772(7):755-65. PubMed ID: 17482433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
    Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
    Gaster M; Beck-Nielsen H
    Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
    Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
    Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased proton leak and SOD2 expression in myotubes from obese non-diabetic subjects with a family history of type 2 diabetes.
    Aguer C; Pasqua M; Thrush AB; Moffat C; McBurney M; Jardine K; Zhang R; Beauchamp B; Dent R; McPherson R; Harper ME
    Biochim Biophys Acta; 2013 Oct; 1832(10):1624-33. PubMed ID: 23685312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hyperglycemia reduces substrate oxidation and impairs metabolic switching of human myotubes.
    Aas V; Hessvik NP; Wettergreen M; Hvammen AW; Hallén S; Thoresen GH; Rustan AC
    Biochim Biophys Acta; 2011 Jan; 1812(1):94-105. PubMed ID: 20888904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes.
    Gaster M
    Biochem Biophys Res Commun; 2011 Jan; 404(4):1023-8. PubMed ID: 21187069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
    Gaster M
    Biochem Biophys Res Commun; 2009 Oct; 387(4):651-5. PubMed ID: 19615969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetic phenotype is preserved in myotubes established from type 2 diabetic subjects: a critical appraisal.
    Gaster M
    APMIS; 2019 Jan; 127(1):3-26. PubMed ID: 30549138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes.
    Wang CH; Wang CC; Huang HC; Wei YH
    FEBS J; 2013 Feb; 280(4):1039-50. PubMed ID: 23253816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects.
    Minet AD; Gaster M
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1486-90. PubMed ID: 21733990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids.
    Corpeleijn E; Hessvik NP; Bakke SS; Levin K; Blaak EE; Thoresen GH; Gaster M; Rustan AC
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E14-22. PubMed ID: 20442319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.
    Gaster M; Beck-Nielsen H
    Biochim Biophys Acta; 2004 Sep; 1690(1):85-91. PubMed ID: 15337174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Contributes to Muscle Insulin Resistance in Mice and Humans.
    Tubbs E; Chanon S; Robert M; Bendridi N; Bidaux G; Chauvin MA; Ji-Cao J; Durand C; Gauvrit-Ramette D; Vidal H; Lefai E; Rieusset J
    Diabetes; 2018 Apr; 67(4):636-650. PubMed ID: 29326365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in type 2 diabetes and obesity.
    Højlund K; Mogensen M; Sahlin K; Beck-Nielsen H
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):713-31, x. PubMed ID: 18775360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
    Hirabara SM; Curi R; Maechler P
    J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial oxidative function and type 2 diabetes.
    Rabøl R; Boushel R; Dela F
    Appl Physiol Nutr Metab; 2006 Dec; 31(6):675-83. PubMed ID: 17213881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
    Gaster M
    Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.